Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.59 per share a year ago.
LOS ANGELES, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.46 per share and net income of

Discounts And 10%+ Yields: 2 BDCs To Buy Now

09:15am, Saturday, 02'nd Aug 2025
I believe BDC investors face higher odds of unfavorable returns over the next 1-3 years due to macro and sector-specific headwinds. Key risks include a negatively sloped interest rate curve, tight spr
Crescent Capital BDC trades at a 26% discount to NAV, which I believe is exaggerated and presents a re-rating opportunity. Despite a rising non-accrual ratio and higher payout, the dividend appears sa
Since the announcement of tariffs in early April, the BDC market has become a less interesting place for capital deployment (as we can imply from higher discounts). Yet, as it is usually the case, hig

2 Deep Value BDCs: One Bargain, One Bust

09:15am, Sunday, 22'nd Jun 2025
Currently, an average BDC trades at an 8% discount to NAV. However, those with high dividend cut probabilities have 20%+ discounts. Many of these heavily punished BDCs are busts.
Let's invest like private equity pros without needing seven figures. Yes, that's right—PE-style starting for as little as $8.
BDCs have entered a challenging period. This is why the market has assigned notable discounts across the board. Some BDCs have become very deeply discounted.

Warning To All BDC Investors

08:00am, Monday, 02'nd Jun 2025
I am increasingly cautious on BDCs due to rising non-accruals, weaker earnings, and looser underwriting amid intense competition for private credit deals. Elevated interest rates are suppressing BDC v
Crescent Capital BDC offers a compelling 10.9% dividend yield and trades at a 22% discount to NAV, providing a strong margin of safety. Recent headwinds, including lower NII and some non-accruals, are
Crescent Capital BDC trades at a significant discount to NAV and offers a high 12.5% yield, but recent performance and total returns have been weak. Rising non-accruals, declining earnings, and weaken
I'm downgrading Crescent Capital from buy to hold due to weakening fundamentals and rising economic uncertainty. Recent earnings showed sequential declines in total and net investment income, with inc

New Strong Sell Stocks for May 19th

08:11am, Monday, 19'th May 2025
BOOT, CCAP and HP have been added to the Zacks Rank #5 (Strong Sell) List on May 19, 2025.
Crescent Capital BDC, Inc. (NASDAQ:CCAP ) Q1 2025 - Earnings Conference Call May 15, 2025 12:00 PM ET Company Participants Dan McMahon - Head, IR Jason Breaux - CEO Henry Chung - President Gerhard Lom
Crescent Capital BDC (CCAP) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.63 per share a year ago.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE